{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:54:31Z","timestamp":1781513671863,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030936","name":"Population Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030936","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ahj.2025.107330","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T16:50:46Z","timestamp":1766422246000},"page":"107330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design and rationale of the HD PCI trial: A cluster randomized crossover trial of higher vs. lower dose heparin for elective percutaneous coronary intervention"],"prefix":"10.1016","volume":"294","author":[{"given":"Marc-Andr\u00e9","family":"d\u2019Entremont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun Fu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harindra C.","family":"Wijeysundera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shy","family":"Amlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Wassef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahar","family":"Lavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek Y.F.","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Betz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Tyrwhitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren J.","family":"Cantor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Bagherli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Vijayaraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjit S.","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2025.107330_bib0001","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.jacc.2020.07.037","article-title":"Comparative trends in percutaneous coronary intervention in Japan and the United States, 2013 to 2017","volume":"76","author":"Inohara","year":"2020","journal-title":"J Am College Cardiol"},{"key":"10.1016\/j.ahj.2025.107330_bib0002","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.2010.1320","article-title":"Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA\/OASIS-8 randomized trial","volume":"304","author":"Steg","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2025.107330_bib0003","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1056\/NEJMoa052711","article-title":"Enoxaparin versus unfractionated Heparin in elective percutaneous coronary intervention","volume":"355","author":"Montalescot","year":"2006","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ahj.2025.107330_bib0004","first-page":"e18","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2025.107330_bib0005","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1093\/eurheartj\/ehw061","article-title":"Anticoagulation in coronary intervention","volume":"37","author":"Zeymer","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2025.107330_bib0006","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/01.CIR.93.4.667","article-title":"Relation between activated clotting time during angioplasty and abrupt closure","volume":"93","author":"Narins","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2025.107330_bib0007","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.008359","article-title":"Trends in arterial access site selection and bleeding outcomes following coronary procedures, 2011-2018","volume":"15","author":"Doll","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2025.107330_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080472","article-title":"Reporting of cluster randomised crossover trials: extension of the CONSORT 2010 statement with explanation and elaboration","volume":"388","author":"McKenzie","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2025.107330_bib0009","unstructured":"Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, and Social Sciences and Humanities Research Council of Canada, Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, 2022."},{"key":"10.1016\/j.ahj.2025.107330_bib0010","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/CIRCOUTCOMES.114.001416","article-title":"The Cardiovascular Health in Ambulatory Care Research Team (CANHEART): using big data to measure and improve cardiovascular health and healthcare services","volume":"8","author":"Tu","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2025.107330_bib0011","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1067\/mhj.2002.123839","article-title":"A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario","volume":"144","author":"Austin","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2025.107330_bib0012","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1097\/MLR.0b013e3182329778","article-title":"Administrative hospitalization database validation of cardiac procedure codes","volume":"51","author":"Lee","year":"2013","journal-title":"Med Care"},{"key":"10.1016\/j.ahj.2025.107330_bib0013","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1002\/sim.3383","article-title":"Sample size calculation for cluster randomized cross-over trials","volume":"27","author":"Giraudeau","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.ahj.2025.107330_bib0014","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/ije\/dyz237","article-title":"A tutorial on sample size calculation for multiple-period cluster randomized parallel, cross-over and stepped-wedge trials using the Shiny CRT Calculator","volume":"49","author":"Hemming","year":"2020","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ahj.2025.107330_bib0015","doi-asserted-by":"crossref","first-page":"m3800","DOI":"10.1136\/bmj.m3800","article-title":"Use of multiple period, cluster randomised, crossover trial designs for comparative effectiveness research","volume":"371","author":"Hemming","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2025.107330_bib0016","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199509213331204","article-title":"Treatment with Bivalirudin (Hirulog) as compared with Heparin during coronary angioplasty for unstable or postinfarction angina","volume":"333","author":"Bittl","year":"1995","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ahj.2025.107330_bib0017","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/01.CIR.0000139868.53594.24","article-title":"Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention","volume":"110","author":"Brener","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2025.107330_bib0018","first-page":"351","article-title":"Defining optimal activated clotting time for percutaneous coronary intervention: a systematic review and bayesian meta-regression","volume":"89","author":"Mottillo","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2025.107330_bib0019","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020609","article-title":"Percutaneous coronary intervention outcomes based on decision-making capacity","volume":"10","author":"Singh","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2025.107330_bib0020","first-page":"S89","article-title":"The evolution of anticoagulation for percutaneous coronary intervention: a 40-year journey","volume":"38","author":"Bainey","year":"2022","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ahj.2025.107330_bib0021","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1161\/CIR.0000000000001328","article-title":"ACC\/AHA\/ACEP\/NAEMSP\/SCAI Guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2025.107330_bib0022","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJMoa0802944","article-title":"Bivalirudin versus unfractionated Heparin during percutaneous coronary intervention","volume":"359","author":"Kastrati","year":"2008","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ahj.2025.107330_bib0023","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMoa1706443","article-title":"Bivalirudin versus Heparin monotherapy in myocardial infarction","volume":"377","author":"Erlinge","year":"2017","journal-title":"N Eng J Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870325003928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870325003928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:16:44Z","timestamp":1781511404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870325003928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":23,"alternative-id":["S0002870325003928"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2025.107330","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and rationale of the HD PCI trial: A cluster randomized crossover trial of higher vs. lower dose heparin for elective percutaneous coronary intervention","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2025.107330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107330"}}